| 注册
首页|期刊导航|中国实用内科杂志|21-羟化酶缺乏症的围孕期管理

21-羟化酶缺乏症的围孕期管理

杨海燕 秦映芬

中国实用内科杂志2024,Vol.44Issue(11):890-895,6.
中国实用内科杂志2024,Vol.44Issue(11):890-895,6.DOI:10.19538/j.nk2024110103

21-羟化酶缺乏症的围孕期管理

Peri-pregnancy management of 21 hydroxylase deficiency

杨海燕 1秦映芬1

作者信息

  • 1. 广西医科大学第一附属医院内分泌科,广西南宁 530021
  • 折叠

摘要

Abstract

The 21-hydroxylase deficiency(21-OHD)is the most common type of congenital adrenal hyperplasia.Although women with 21-OHD have declined fertility,they are still able to conceive.Both parties preparing for pregnancy should undergo genetic testing and consult genetic experts before pregnancy.If necessary,the methods such as in vitro fertilization and preimplantation genetic testing should be used to achieve optimal fertility.The 21-OHD women need to adjust glucocorticoids and mineralocorticoids before and during pregnancy,as well as on and after delivery,and postpartum,and should avoid adrenal crisis.We also have corresponding recommendations for monitoring indicators,prenatal diagnosis and treatment,and postpartum management during the perinatal period for 21-OHD female.The entire perinatal period requires experienced endocrinology,obstetrics,and genetic counseling experts to jointly manage.

关键词

21-羟化酶缺乏症/生育/妊娠/产前治疗/糖皮质激素

Key words

21-hydroxylase deficiency/fertility/pregnancy/prenatal therapy/glucocorticoid

分类

医药卫生

引用本文复制引用

杨海燕,秦映芬..21-羟化酶缺乏症的围孕期管理[J].中国实用内科杂志,2024,44(11):890-895,6.

中国实用内科杂志

OA北大核心CSTPCD

1005-2194

访问量0
|
下载量0
段落导航相关论文